JP2019001816A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019001816A5 JP2019001816A5 JP2018169278A JP2018169278A JP2019001816A5 JP 2019001816 A5 JP2019001816 A5 JP 2019001816A5 JP 2018169278 A JP2018169278 A JP 2018169278A JP 2018169278 A JP2018169278 A JP 2018169278A JP 2019001816 A5 JP2019001816 A5 JP 2019001816A5
- Authority
- JP
- Japan
- Prior art keywords
- pill
- sustained release
- active substance
- abuse deterrent
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006187 pill Substances 0.000 claims 34
- 238000013268 sustained release Methods 0.000 claims 23
- 239000012730 sustained-release form Substances 0.000 claims 23
- 239000013543 active substance Substances 0.000 claims 19
- 239000003795 chemical substances by application Substances 0.000 claims 11
- 238000013270 controlled release Methods 0.000 claims 8
- 239000004014 plasticizer Substances 0.000 claims 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 7
- 239000012530 fluid Substances 0.000 claims 7
- 230000002496 gastric effect Effects 0.000 claims 7
- 239000002202 Polyethylene glycol Substances 0.000 claims 6
- 229920001223 polyethylene glycol Polymers 0.000 claims 6
- 239000011159 matrix material Substances 0.000 claims 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- 239000011118 polyvinyl acetate Substances 0.000 claims 4
- 229920002689 polyvinyl acetate Polymers 0.000 claims 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 3
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical group O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 3
- 229960002085 oxycodone Drugs 0.000 claims 3
- 239000004322 Butylated hydroxytoluene Substances 0.000 claims 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims 2
- UQCNKQCJZOAFTQ-ISWURRPUSA-N Oxymorphone Chemical compound O([C@H]1C(CC[C@]23O)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O UQCNKQCJZOAFTQ-ISWURRPUSA-N 0.000 claims 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 claims 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 claims 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 claims 2
- 229960005118 oxymorphone Drugs 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims 2
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 claims 1
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 claims 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 claims 1
- 239000001856 Ethyl cellulose Substances 0.000 claims 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 claims 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 235000006708 antioxidants Nutrition 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 claims 1
- 235000015165 citric acid Nutrition 0.000 claims 1
- 229960004106 citric acid Drugs 0.000 claims 1
- -1 controlled release Substances 0.000 claims 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 1
- XYYVYLMBEZUESM-UHFFFAOYSA-N dihydrocodeine Natural products C1C(N(CCC234)C)C2C=CC(=O)C3OC2=C4C1=CC=C2OC XYYVYLMBEZUESM-UHFFFAOYSA-N 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000000975 dye Substances 0.000 claims 1
- 235000010350 erythorbic acid Nutrition 0.000 claims 1
- 239000004318 erythorbic acid Substances 0.000 claims 1
- 229920001249 ethyl cellulose Polymers 0.000 claims 1
- 235000019325 ethyl cellulose Nutrition 0.000 claims 1
- 238000013265 extended release Methods 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- LLPOLZWFYMWNKH-CMKMFDCUSA-N hydrocodone Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)CC(=O)[C@@H]1OC1=C2C3=CC=C1OC LLPOLZWFYMWNKH-CMKMFDCUSA-N 0.000 claims 1
- 229960000240 hydrocodone Drugs 0.000 claims 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 claims 1
- WVLOADHCBXTIJK-YNHQPCIGSA-N hydromorphone Chemical compound O([C@H]1C(CC[C@H]23)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O WVLOADHCBXTIJK-YNHQPCIGSA-N 0.000 claims 1
- 229960001410 hydromorphone Drugs 0.000 claims 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 claims 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 229940026239 isoascorbic acid Drugs 0.000 claims 1
- 229940099563 lactobionic acid Drugs 0.000 claims 1
- 229960001797 methadone Drugs 0.000 claims 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims 1
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 claims 1
- 229960005181 morphine Drugs 0.000 claims 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical compound O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 claims 1
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 claims 1
- 229940043349 potassium metabisulfite Drugs 0.000 claims 1
- 235000010263 potassium metabisulphite Nutrition 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 235000010388 propyl gallate Nutrition 0.000 claims 1
- 239000000473 propyl gallate Substances 0.000 claims 1
- 229940075579 propyl gallate Drugs 0.000 claims 1
- 229940080308 racemethionine Drugs 0.000 claims 1
- XWGJFPHUCFXLBL-UHFFFAOYSA-M rongalite Chemical compound [Na+].OCS([O-])=O XWGJFPHUCFXLBL-UHFFFAOYSA-M 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- 229940001607 sodium bisulfite Drugs 0.000 claims 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims 1
- 235000010262 sodium metabisulphite Nutrition 0.000 claims 1
- 235000010265 sodium sulphite Nutrition 0.000 claims 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 claims 1
- 235000019345 sodium thiosulphate Nutrition 0.000 claims 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 claims 1
- 235000010384 tocopherol Nutrition 0.000 claims 1
- 229960001295 tocopherol Drugs 0.000 claims 1
- 229930003799 tocopherol Natural products 0.000 claims 1
- 239000011732 tocopherol Substances 0.000 claims 1
- LLPOLZWFYMWNKH-UHFFFAOYSA-N trans-dihydrocodeinone Natural products C1C(N(CCC234)C)C2CCC(=O)C3OC2=C4C1=CC=C2OC LLPOLZWFYMWNKH-UHFFFAOYSA-N 0.000 claims 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims 1
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361917120P | 2013-12-17 | 2013-12-17 | |
| US201361917074P | 2013-12-17 | 2013-12-17 | |
| US61/917,120 | 2013-12-17 | ||
| US61/917,074 | 2013-12-17 | ||
| US201461980259P | 2014-04-16 | 2014-04-16 | |
| US201461980254P | 2014-04-16 | 2014-04-16 | |
| US61/980,254 | 2014-04-16 | ||
| US61/980,259 | 2014-04-16 | ||
| US14/457,714 US10195153B2 (en) | 2013-08-12 | 2014-08-12 | Extruded immediate release abuse deterrent pill |
| US14/457,714 | 2014-08-12 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016540580A Division JP6403780B2 (ja) | 2013-12-17 | 2014-12-17 | 押出成形された持続放出性乱用抑止性丸剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019001816A JP2019001816A (ja) | 2019-01-10 |
| JP2019001816A5 true JP2019001816A5 (enExample) | 2019-04-25 |
| JP6678212B2 JP6678212B2 (ja) | 2020-04-08 |
Family
ID=53403652
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016540580A Expired - Fee Related JP6403780B2 (ja) | 2013-12-17 | 2014-12-17 | 押出成形された持続放出性乱用抑止性丸剤 |
| JP2018169278A Expired - Fee Related JP6678212B2 (ja) | 2013-12-17 | 2018-09-11 | 押出成形された持続放出性乱用抑止性丸剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016540580A Expired - Fee Related JP6403780B2 (ja) | 2013-12-17 | 2014-12-17 | 押出成形された持続放出性乱用抑止性丸剤 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3082775A4 (enExample) |
| JP (2) | JP6403780B2 (enExample) |
| AU (3) | AU2014364800A1 (enExample) |
| CA (1) | CA2934078C (enExample) |
| WO (1) | WO2015095387A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014364800A1 (en) * | 2013-12-17 | 2016-07-07 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| IL273627B2 (en) | 2017-12-20 | 2025-03-01 | Purdue Pharma Lp | Morphine sulfate dosage forms for abuse deterrence |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2065055A1 (en) * | 1996-06-26 | 2009-06-03 | Board of Regents, The University of Texas System | Holt-melt extrudable pharmaceutical formulation |
| FI1765303T4 (fi) * | 2004-07-01 | 2023-01-31 | Väärinkäytöltä suojattu oraalinen tabletti | |
| US20080152595A1 (en) * | 2004-11-24 | 2008-06-26 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of orally administered pharmaceutical products |
| DE102007011485A1 (de) * | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Darreichungsform mit erschwertem Missbrauch |
| GB0909680D0 (en) * | 2009-06-05 | 2009-07-22 | Euro Celtique Sa | Dosage form |
| EA201400172A1 (ru) * | 2011-07-29 | 2014-06-30 | Грюненталь Гмбх | Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства |
| ES2644935T3 (es) * | 2012-04-18 | 2017-12-01 | Mallinckrodt Llc | Composiciones farmacéuticas de liberación inmediata con propiedades disuasorias del abuso |
| US9549899B2 (en) * | 2012-07-06 | 2017-01-24 | Egalet Ltd. | Abuse deterrent pharmaceutical compositions for controlled release |
| CA2919892C (en) * | 2013-08-12 | 2019-06-18 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
| AU2014364800A1 (en) * | 2013-12-17 | 2016-07-07 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
-
2014
- 2014-12-17 AU AU2014364800A patent/AU2014364800A1/en not_active Abandoned
- 2014-12-17 EP EP14871095.7A patent/EP3082775A4/en not_active Withdrawn
- 2014-12-17 WO PCT/US2014/070942 patent/WO2015095387A1/en not_active Ceased
- 2014-12-17 CA CA2934078A patent/CA2934078C/en not_active Expired - Fee Related
- 2014-12-17 JP JP2016540580A patent/JP6403780B2/ja not_active Expired - Fee Related
-
2018
- 2018-09-11 JP JP2018169278A patent/JP6678212B2/ja not_active Expired - Fee Related
- 2018-10-25 AU AU2018253567A patent/AU2018253567B2/en not_active Ceased
-
2019
- 2019-08-16 AU AU2019216710A patent/AU2019216710A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2360102T3 (es) | Sistema para la liberación controlada de morfina. | |
| JP7347474B2 (ja) | 経口フィルム製剤 | |
| US11590127B2 (en) | Gastro-resistant formulation containing posaconazole | |
| US20110171297A1 (en) | Sustained release formulation for venlafaxine hydrochloride | |
| US20210308040A1 (en) | Ketamine oral transmucosal delivery system | |
| JP2018517676A5 (enExample) | ||
| JP2009545560A5 (enExample) | ||
| JPWO2008084698A1 (ja) | タクロリムス徐放性医薬組成物 | |
| CN102641254A (zh) | 阿司匹林肠溶缓释制剂的制备方法 | |
| KR102727681B1 (ko) | 덱스란소프라졸 또는 이의 약학적으로 허용 가능한 염을 함유하는 안정한 경구투여용 약학 제제 | |
| KR20080048461A (ko) | 위장체류 제제 및 이의 제조 방법 | |
| JP2019001816A5 (enExample) | ||
| CN109985016A (zh) | 一种非布司他的控释组合物及其制备方法 | |
| JP2001039876A (ja) | Ｎｓａｉｄ及びミソプロストールを含む医薬錠剤 | |
| KR102298473B1 (ko) | 제어 방출 제약 투여 형태 | |
| RU2018137590A (ru) | Фармацевтические композиции для производного n-пропаргиламина | |
| KR20140131205A (ko) | 수용성 활성성분을 함유하는 서방형 약제학적 조성물 | |
| US20180008558A1 (en) | Extended release compositions of an aminoalkyl nitrate | |
| AU2016231883A1 (en) | Pharmaceutical compositions of dimethyl fumarate | |
| EP4424308A2 (en) | Gastro-resistant formulation containing posaconazole and a polymeric precipitation inhibitor | |
| WO2017125856A1 (en) | Formulations in modified-release tablets containing high-dosage mesalazine, process for their preparation and their use | |
| CN102552205A (zh) | 一种枸橼酸钾控释片制剂及其制备方法 | |
| CN104146979A (zh) | 盐酸普拉克索缓释片及制备方法 | |
| WO2023090719A1 (ko) | 산 민감성 성분을 포함하는 삼투성 제제 조성물 | |
| HK1122729B (en) | Gastroretentive formulations and manufacturing process thereof |